This session will educate the audience on how to incorporate genetic and genomic testing insights into clinical practice in order to guide personalized and preventative care and optimize surgical decision making for patients.

  • Describe the importance of risk assessment and genetic testing to stratify a patient's breast cancer risk.
  • Discuss germline testing to aid in breast cancer surgical decision-making and prevent future cancers.
  • Review tools and resources for implementing genetic testing in clinical practice.

Hear from our Speakers

Dr. David Weintritt MD, FACS Breast Cancer Surgeon at Virginia Cancer Specialists

Laura Brzeskiewicz MS, CGC